Deutsche Bank has recently raised Boston Scientific Corp (BSX) stock to Buy rating, as announced on January 10, 2025, according to Finviz. Earlier, on October 18, 2024, Needham had reduced the stock ...

The market values Boston Scientific quality package that sent Boston Scientific's stock rose nearing its 52-week high with its current price of $95.95 per share, or $33.12 above the GF Value of $ ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Boston Scientific Corp (NYSE:BSX) stands against the other ...

Boston Scientific’s BSX robust expansion of operations across different geographies outside the United States is poised to help it grow in the upcoming quarters. The company’s ...

Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. The smooth upward movement of the stock indicates the quality of its investor base.

Boston Scientific Corp (BSX) stock saw a decline, ending the day at $100.31 which represents a decrease of $-0.60 or -0.59% from the prior close of $100.91. The stock opened at $100.91 and touched a ...